Full Press Release Details
National Stock Exchange of India Ltd. (Scrip Code:
BSE Limited (Scrip Code: 500124)
Sub: Intimation under Regulation 30 of the Securities and Exchange
Board of India (Listing Obligations and Disclosure Requirements) Regulations, 2015 - Schedule of Analyst / Institutional Investor Meetings
This is to inform you that the Company's management will be participating
in the following investor conferences / group investor meetings:
| Date | Meeting | Location |
| 28 th Feb' 2023 | BofA Healthcare Tour | Hyderabad |
| 28 th Feb' 2023 | Ambit India Access - Healthcare Tour | Hyderabad |
| 2 nd Mar' 2023 | Goldman Sachs India Pharma and Healthcare Tour | Hyderabad |
| 2 nd Mar' 2023 | Investor Group meeting | Singapore |
Please note that the schedule of the aforesaid meeting is subject to
change due to any exigencies on the part of Investors / Company.
This is for your information.
For Dr. Reddy's Laboratories Limited
| /s/ K Randhir Singh | |
| K Randhir Singh |
Company Secretary, Compliance Officer and
CC:- New York Stock Exchange Inc.(Stock Code :RDY)